AIM ImmunoTech Net Other Investing Changes (Quarterly) Insights

AIM ImmunoTech, Inc. (AIM)

1.25 +0.08 (+6.84%) USD | NYAM | Jan 22, 13:09

View Net Other Investing Changes (Quarterly) for AIM.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Net Other Investing Changes (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Net Other Investing Changes (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Net Other Investing Changes (Quarterly) Benchmarks

Start Trial

Halozyme Therapeutics, Inc.	--
Perspective Therapeutics, Inc.	Upgrade
Protalix Biotherapeutics, Inc.	Upgrade
Electromed, Inc.	--
Armata Pharmaceuticals, Inc.	--